At a glance
- Originator Wyeth
- Class Antipsychotics
- Mechanism of Action Dopamine D2 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 09 Oct 2000 No-Development-Reported for Psychotic disorders in USA (Unknown route)
- 27 May 1998 New profile
- 27 May 1998 Preclinical development for Psychotic disorders in USA (Unknown route)